Item 9A. Controls and Procedures
ITEM 9A. CONTROLS AND PROCEDURES
a) An evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a -15(e) and 15d-15(e) promulgated under the Securities and Exchange Act of 1934, as amended) as of December 31, 2025. Based on that evaluation, the Company’s management, including the Chief Executive Officer and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective.
b) MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
The management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities and Exchange Act of 1934. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles ("GAAP").
The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2025. In making this assessment, management used the 2013 criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on our assessment and those criteria, management concluded that the Company maintained effective internal control over financial reporting as of December 31, 2025.
The Company’s independent registered public accounting firm ( Crowe LLP - PCAOB ID: 173 ) has issued their report on the Company’s internal control over financial reporting. That report appears under the heading, Report of Independent Registered Public Accounting Firm.
c) There have been no changes in the Company’s internal controls during the previous fiscal quarter, ended December 31, 2025, that have materially affected, or are reasonably likely to materially affect the Company’s internal control over financial reporting.
ITEM 9B. OTHER INFORMATION
During the three months ended December 31, 2025, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not applicable.
123
Table of Contents
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information required in response to this item will be contained under the captions "Election of Directors," "Corporate Governance and the Board of Directors" and "Delinquent Section 16(a) Reports" in the definitive Proxy Statement for the Annual Meeting of Shareholders to be held on April 14, 2026, to be filed with the SEC on Form DEF 14A, and such sections are incorporated herein by reference in response to this Item.
ITEM 11. EXECUTIVE COMPENSATION
The information required in response to this item will be contained under the captions "Director Compensation," "Executive Compensation," "Compensation Committee Interlocks and Insider Participation," "Compensation Discussion and Analysis," "Policies and Practices Related to the Grant of Certain Equity Awards," and "Compensation Committee Report" in the definitive Proxy Statement, for the Annual Meeting of Shareholders to be held on April 14, 2026, to be filed with the SEC on Form DEF 14A, is incorporated herein by reference in response to this Item. The information included under the heading "Compensation Committee Report" in the Proxy Statement shall not be deemed "soliciting" materials or to be "filed" with the SEC or subject to Regulation 14A or 14C, or to the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS
The information appearing under the caption "Security Ownership of Certain Beneficial Owners and Management" in the definitive Proxy Statement, for the Annual Meeting of Shareholders to be held on April 14, 2026, to be filed with the SEC on Form DEF 14A, is incorporated herein by reference in response to this Item.
Equity Compensation Plan Information
The table below sets forth the following information as of December 31, 2025 for (i) all compensation plans previously approved by the Company’s stockholders and (ii) all compensation plans not previously approved by the Company’s stockholders:
(a) the number of securities to be issued upon the exercise of outstanding options, warrants and rights;
(b) the weighted-average exercise price of such outstanding options, warrants and rights; and
(c) other than securities to be issued upon the exercise of such outstanding options, warrants and rights, the number of securities remaining available for future issuance under the plans.
EQUITY COMPENSATION PLAN INFORMATION
Plan category Number of securities to be issued upon exercise of outstanding options Weighted-average exercise price of outstanding options Number of securities remaining available for future issuance under equity compensation plans
Equity compensation plans approved by security holders (1)(2)(3)
293,549 $ 0 22,548
Equity compensation plans not approved by security holders 0 0 0
Total 293,549 $ 0 22,548
(1) Lakeland Financial Corporation 2017 Equity Incentive Plan was adopted on April 12, 2017 by the board of directors. Amounts shown reflects share activity related to the 2017 Equity Incentive Plan.
(2) This amount includes 80,365 time-based restricted stock units and 213,184 performance based restricted stock units under the 2017 Equity Incentive Plan. The number of shares of the Company's common stock that may be issued pursuant to outstanding unearned performance-based restricted stock units reflects actual performance.
124
Table of Contents
(3) The Lakeland Financial Corporation 2025 Equity Incentive Plan was adopted on April 9, 2025 by the board of directors; however, there were no shares granted under this plan during 2025. There are 1,100,000 shares remaining for future issuance under the 2025 Equity Incentive Plan.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information appearing under the caption "Certain Relationships and Related Transactions" in the definitive Proxy Statement, for the Annual Meeting of Shareholders to be held on April 14, 2026, to be with the SEC on Form DEF 14A, is incorporated herein by reference in response to this Item. Certain additional information on related party transactions is also included in Note 13 - Related Party Transactions to the Company’s financial statements contained in Item 8.
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information appearing under the caption "Fees Paid to Independent Registered Public Accounting Firm" in the definitive Proxy Statement, for the Annual Meeting of Shareholders to be held on April 14, 2026, to be filed with the SEC on Form DEF 14A, is incorporated herein by reference in response to this Item.
125
Table of Contents
PART IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) The following financial statements are filed as part of this annual report:
Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets as of December 31, 2025 and 2024
Consolidated Statements of Income, years ended December 31, 2025, 2024 and 2023
Consolidated Statements of Comprehensive Income, years ended December 31, 2025, 2024 and 2023
Consolidated Statements of Stockholders' Equity, years ended December 31, 2025, 2024 and 2023
Consolidated Statements of Cash Flows, years ended December 31, 2025, 2024 and 2023
Notes to the Consolidated Financial Statements
(b) Exhibits
Exhibit No. Document Location
3.1 Amended and Restated Articles of Incorporation of Lakeland Financial Corporation
Exhibit 3.1 to the Company's Form 10-K for the fiscal year ended December 31, 2022
3.2 Restated Bylaws of Lakeland Financial Corporation, as amended
Exhibit 3.1 to the Company's Form 10-K for the fiscal year ended December 31, 2022
4.1 Form of Common Stock Certificate
Exhibit 4.1 to the Company’s Form 10-K for the fiscal year ended December 31, 2003
4.2 Description of Securities
Exhibit 4.4 to the Company's Form 10-K for the fiscal year ended December 31, 2019
10.1* Lakeland Financial Corporation 2008 Equity Incentive Plan
Exhibit 10.1 to the Company’s Form S-8 filed on May 14, 2008
10.2* Amended and Restated Lakeland Financial Corporation Director’s Fee Deferral Plan
Exhibit 10.4 to the Company’s Form 10-K for the fiscal year ended December 31, 2008
10.3* Form of Change in Control Agreement entered into with David M. Findlay, Kevin L. Deardorff, Eric H. Ottinger, Michael E. Gavin, Lisa M. O’Neill and Kristin L. Pruitt
Exhibit 10.1 of the Company’s Form 8-K filed on March 2, 2016
10.4* Amended and Restated Employee Deferred Compensation Plan
Exhibit 10.7 to the Company’s Form 10-K for the fiscal year ended December 31, 2008
10.5* First Amendment to Amended and Restated Employee Deferred Compensation Plan
Exhibit 10.6 to the Company's Form 10-K for the fiscal year ended December 31, 2020
10.6* Executive Incentive Bonus Plan
Exhibit 10.11 to the Company’s Form 10-K for the fiscal year ended December 31, 2004
10.7* Amended and Restated Long Term Incentive Plan
Exhibit 10.1 to the Company’s Form10-Q for the quarter ended September 30, 2009
10.8* Lakeland Financial Corporation 2013 Equity Incentive Plan
Appendix A to the Definitive Proxy Statement on Form DEF-14A filed on March 4, 2013
126
Table of Contents
10.9* Form of Restricted Stock Award Agreement
Exhibit 4.3 to the Company’s Form S-8 filed on July 9, 2013
10.10* Form of Nonqualified Stock Option Award Agreement
Exhibit 4.4 to the Company’s Form S-8 filed on July 9, 2013
10.11* Form of Restricted Stock Unit Award Agreement
Exhibit 4.5 to the Company’s Form S-8 filed on July 9, 2013
10.12* Lakeland Financial Corporation 2017 Equity Incentive Plan
Exhibit 4.5 to the Company’s Form S-8 filed on April 13, 2017
10.13* Form of Restricted Stock Unit Award Agreement
Exhibit 4.6 to the Company’s Form S-8 filed on April 13, 2017
10.14* Form of Restricted Stock Award Agreement
Exhibit 4.7 to the Company’s Form S-8 filed on April 13, 2017
10.15* Form of Restricted Stock Award Agreement
Exhibit 4.8 to the Company’s Form S-8 filed on April 13, 2017
10.16* Form of Nonqualified Stock Option Award Agreement
Exhibit 4.9 to the Company’s Form S-8 filed on April 13, 2017
10.17* Lakeland Financial Corporation Amended and Restated 2017 Equity Incentive Plan
Exhibit 10.1 to the Company's Form 10-Q for the quarter ended September 30, 2021
10.18* Form of Lakeland Financial Corporation 2017 Amended and Restated Equity Incentive Plan Time-Based Restricted Stock Unit Award Agreement
Exhibit 10.1 to the Company's Form 8-K filed on January 31, 2025
10.19* Form of Lakeland Financial Corporation 2017 Amended and Restated Equity Incentive Plan Performance-Based Restricted Stock Unit Award Agreement
Exhibit 10.2 to the Company's Form 8-K filed on January 31, 2025
10.20* Lakeland Financial Corporation 2025 Equity Incentive Plan
Exhibit 10.1 to the Company's Form 8-K filed on April 9, 2025
10.21* Form of Lakeland Financial Corporation 2025 Equity Incentive Plan Time-Based Restricted Stock Unit Award Agreement
Exhibit 99.2 to the Company's Form S-8 filed on April 9, 2025
10.22* Form of Lakeland Financial Corporation 2025 Equity Incentive Plan Performance-Based Restricted Stock Unit Award Agreement
Exhibit 99.3 to the Company's Form S-8 filed on April 9, 2025
19.1 Lakeland Financial Corporation Insider Trading Policy
Exhibit 19.1 to the Company's Form 10-K filed on February 21, 2024
21.1 Subsidiaries
Attached hereto
23.1 Consent of Independent Registered Public Accounting Firm
Attached hereto
31.1 Certification of Chief Executive Officer Pursuant to Rule 13a-15(e)/15d-15(e) and 13(a)-15(f)/15d-15(f)
Attached hereto
31.2 Certification of Chief Financial Officer Pursuant to Rule 13a-15(e)/15d-15(e) and 13(a)-15(f)/15d-15(f)
Attached hereto
127
Table of Contents
32.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Attached hereto
32.2 Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Attached hereto
97.1 Clawback Policy
Exhibit 97.1 to the Company's Form 10-K filed on February 21, 2024
* Management contract or compensatory plan or arrangement.
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document contained in Exhibit 101
ITEM 16. FORM 10-K SUMMARY
None.
128
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 15(d) of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
LAKELAND FINANCIAL CORPORATION
Date: February 25, 2026
By /s/ David M. Findlay
David M. Findlay, Chairman and Chief Executive Officer
Pursuant to the requirements of the Securities and Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Name Title Date
/s/ David M. Findlay
David M. Findlay Chairman and Chief Executive Officer February 25, 2026
(principal executive officer)
/s/ Kristin L. Pruitt
Kristin L. Pruitt President and Director February 25, 2026
/s/ Lisa M. O'Neill
Lisa M. O’Neill Executive Vice President, Chief Financial Officer February 25, 2026
(principal financial officer)
/s/ Brok A. Lahrman
Brok A. Lahrman Senior Vice President, Finance and Chief Accounting Officer February 25, 2026
(principal accounting officer)
/s/ A. Faraz Abbasi
A. Faraz Abbasi Director February 25, 2026
/s/ Blake W. Augsburger
Blake W. Augsburger Director February 25, 2026
/s/ Robert E. Bartels, Jr.
Robert E. Bartels, Jr. Director February 25, 2026
/s/ Darrianne P. Christian
Darrianne P. Christian Director February 25, 2026
/s/ Melinda J. Creighton Truex
Melinda J. Creighton Truex Director February 25, 2026
/s/ Emily E. Pichon
Emily E. Pichon Director February 25, 2026
129
Table of Contents
/s/ Steven D. Ross
Steven D. Ross Director February 25, 2026
/s/ Brian J. Smith
Brian J. Smith Director February 25, 2026
/s/ Daniel B. Starr
Daniel B. Starr Director February 25, 2026
/s/ Bradley J. Toothaker
Bradley J. Toothaker Director February 25, 2026
/s/ M. Scott Welch
M. Scott Welch Director February 25, 2026
130
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.